169
Views
8
CrossRef citations to date
0
Altmetric
Letter to the Editor

Treatment of CD33 positive refractory acute lymphoblastic leukemia with Mylotarg

, &
Pages 596-597 | Received 06 Nov 2007, Accepted 19 Dec 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pier Paolo Piccaluga, Mario Arpinati, Anna Candoni, Claudio Laterza, Stefania Paolini, Anna Gazzola, Elena Sabattini, Giuseppe Visani & Stefano A. Pileri. (2011) Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia. Leukemia & Lymphoma 52:2, pages 325-327.
Read now

Articles from other publishers (7)

Jason H. Rogers, Rohit Gupta, Jaime M. Reyes, Michael Gundry, Geraldo Medrano, Anna Guzman, Rogelio Aguilar, Shannon E. Conneely, Tidie Song, Cade Anthony Johnson, Sean Barnes, Carlo D.D. Cristobal, Kristen Kurtz, Lorenzo Brunetti, Margaret A Goodell & Rachel E. Rau. (2021) Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities . Blood Advances.
Crossref
Aditi Vedi & David S. Ziegler. (2014) Antibody Therapy for Pediatric Leukemia. Frontiers in Oncology 4.
Crossref
Elisabeth Paietta. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 241 283 .
Dieter Hoelzer & Nicola Gökbuget. (2012) Chemoimmunotherapy in acute lymphoblastic leukemia. Blood Reviews 26:1, pages 25-32.
Crossref
Dieter Hoelzer. (2011) Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia. Hematology 2011:1, pages 243-249.
Crossref
Elisabeth Paietta. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia 365 381 .
Michael A. Batey & Josef H. Vormoor. 2011. New Agents for the Treatment of Acute Lymphoblastic Leukemia. New Agents for the Treatment of Acute Lymphoblastic Leukemia 105 115 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.